Suppr超能文献

PhoY2 而非 PhoY1 是分枝杆菌中与持久菌相关的 PhoU 同源物。

PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis.

机构信息

Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

出版信息

J Antimicrob Chemother. 2010 Jun;65(6):1237-42. doi: 10.1093/jac/dkq103. Epub 2010 Apr 1.

Abstract

OBJECTIVES

Mycobacterial persistence is thought to be the underlying cause of the current lengthy tuberculosis therapy and latent infection. Despite some recent progress, the mechanisms of bacterial persistence are poorly understood. We have recently identified a new persister gene phoU from Escherichia coli and have shown that the phoU mutant has a defect in persisters. The objective of this study is to evaluate the role of two phoU homologues phoY1 and phoY2 from Mycobacterium tuberculosis in mycobacterial persistence.

METHODS

M. tuberculosis phoY1 and phoY2 mutant strains were constructed. The persister-related phenotypes of the phoY1 and phoY2 mutants were assessed in vitro by MIC testing, drug exposure assays and also by survival in the mouse model of tuberculosis infection.

RESULTS

We demonstrated that M. tuberculosis PhoY2 is the equivalent of E. coli PhoU in that inactivation of phoY2 but not phoY1 caused a defect in persistence phenotype as shown by increased susceptibility to rifampicin and pyrazinamide in both MIC testing and drug exposure assays and also reduced persistence in the mouse model.

CONCLUSIONS

This study provides further validation that PhoU is involved in persistence not only in E. coli but also in M. tuberculosis and has implications for the development of new drugs targeting persisters for improved treatment.

摘要

目的

分枝杆菌的持续存在被认为是目前结核病治疗时间长和潜伏感染的根本原因。尽管最近取得了一些进展,但细菌持续存在的机制仍知之甚少。我们最近从大肠杆菌中鉴定出一种新的持续生存基因 phoU,并表明 phoU 突变体在持续生存方面存在缺陷。本研究的目的是评估分枝杆菌 phoY1 和 phoY2 两种同源物在分枝杆菌持续存在中的作用。

方法

构建了结核分枝杆菌 phoY1 和 phoY2 突变株。通过 MIC 试验、药物暴露试验以及在结核分枝杆菌感染小鼠模型中的存活情况,评估了 phoY1 和 phoY2 突变体的持续生存相关表型。

结果

我们证明,结核分枝杆菌 PhoY2 相当于大肠杆菌 PhoU,因为 phoY2 的失活而不是 phoY1 的失活导致了持续生存表型的缺陷,表现在 MIC 试验和药物暴露试验中对利福平和顺铂的敏感性增加,以及在小鼠模型中持续生存能力降低。

结论

这项研究进一步验证了 PhoU 不仅参与了大肠杆菌的持续生存,也参与了结核分枝杆菌的持续生存,这对开发针对持续生存菌的新药物以改善治疗具有重要意义。

相似文献

1
PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis.
J Antimicrob Chemother. 2010 Jun;65(6):1237-42. doi: 10.1093/jac/dkq103. Epub 2010 Apr 1.
2
PhoY Proteins Promote Persister Formation by Mediating Pst/SenX3-RegX3 Phosphate Sensing.
mBio. 2017 Jul 11;8(4):e00494-17. doi: 10.1128/mBio.00494-17.
4
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
Antimicrob Agents Chemother. 2007 Jun;51(6):2092-9. doi: 10.1128/AAC.00052-07. Epub 2007 Apr 9.
7
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5198-207. doi: 10.1128/AAC.00826-16. Print 2016 Sep.
9
Crystal structure of PhoU from Pseudomonas aeruginosa, a negative regulator of the Pho regulon.
J Struct Biol. 2014 Oct;188(1):22-9. doi: 10.1016/j.jsb.2014.08.010. Epub 2014 Sep 8.

引用本文的文献

2
Bacterial persisters: molecular mechanisms and therapeutic development.
Signal Transduct Target Ther. 2024 Jul 17;9(1):174. doi: 10.1038/s41392-024-01866-5.
3
A Bibliometric Analysis of Research on Bacterial Persisters.
Biomed Res Int. 2023 Jan 6;2023:4302914. doi: 10.1155/2023/4302914. eCollection 2023.
6
Insights into the molecular determinants involved in persistence and their therapeutic implications.
Virulence. 2021 Dec;12(1):2721-2749. doi: 10.1080/21505594.2021.1990660.
7
Mechanisms of Antibiotic Tolerance in Complex: Lessons From Related Mycobacteria.
Front Microbiol. 2020 Sep 30;11:573983. doi: 10.3389/fmicb.2020.573983. eCollection 2020.
9
PhoU Homologs Regulate Persister Formation and Virulence.
Front Microbiol. 2020 May 26;11:865. doi: 10.3389/fmicb.2020.00865. eCollection 2020.

本文引用的文献

1
Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli.
FEMS Microbiol Lett. 2010 Feb;303(1):33-40. doi: 10.1111/j.1574-6968.2009.01857.x. Epub 2009 Nov 17.
3
Insights into the molecular basis of L-form formation and survival in Escherichia coli.
PLoS One. 2009 Oct 6;4(10):e7316. doi: 10.1371/journal.pone.0007316.
4
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
Antimicrob Agents Chemother. 2008 Aug;52(8):2718-26. doi: 10.1128/AAC.00144-08. Epub 2008 Jun 2.
5
[XDR-TB, extensively drug-resistant tuberculosis].
Biomedica. 2007 Dec;27(4):473-4. doi: 10.7705/biomedica.v27i4.167.
6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
Antimicrob Agents Chemother. 2007 Jun;51(6):2092-9. doi: 10.1128/AAC.00052-07. Epub 2007 Apr 9.
7
Temporal gene-expression in Escherichia coli K-12 biofilms.
Environ Microbiol. 2007 Feb;9(2):332-46. doi: 10.1111/j.1462-2920.2006.01143.x.
8
Persister cells, dormancy and infectious disease.
Nat Rev Microbiol. 2007 Jan;5(1):48-56. doi: 10.1038/nrmicro1557. Epub 2006 Dec 4.
10
Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
J Antimicrob Chemother. 2006 Nov;58(5):936-41. doi: 10.1093/jac/dkl358. Epub 2006 Sep 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验